Table 4. miRs are up- and down-regulated in PBMCs of asthmatic subjects compared to healthy controls after virus infection (RSV and IFV).
| Virus type | miR | Regulation in asthmatics | Role/pathway/target | Reference |
|---|---|---|---|---|
| RSV | miR-320e | ↓ | Pathways: inflammatory, immune response, Wnt, TGF-β, insulin, and T- and B-cell receptor signalling | 100 |
| miR-320d | ↓ | - | 100 | |
| miR-877-5p | ↓ | - | 100 | |
| miR-122-5p | ↓ | - | 100 | |
| miR-92b-5p | ↓ | - | 100 | |
| miR-106b-5p | ↑ | - | 100 | |
| miR-20b-5p | ↑ | - | 100 | |
| miR-342-3p | ↑ | - | 100 | |
| miR-26b | ↑ | Target: TLR4, IFN-β, CCL5 | 99 | |
| IFV | miR-26a | ↓ | Target: IFN-α/β | 106 |
| miR-650 | ↓ | Pathway: innate immunity | 101 | |
| Target: IFIT2, MXA | ||||
| miR-451a | ↑ | Pathway: type I IFN | 102 | |
| Target: IL-6 | ||||
| miR-3123 | ↑ | - | 104 | |
| miR-342-5p | ↑ | Pathway: sterol biosynthesis | 105 |
PBMC, peripheral blood mononuclear cell; RSV, respiratory syncytial virus; IFV, influenza virus.